LIFECARE PCA 3
Report
- Report Number
- 2921482-2008-00295
- Event Type
- Injury
- Date Received
- September 15, 2008
- Date of Event
- August 20, 2008
- Report Date
- August 25, 2008
- Manufacturer
- HOSPIRA, INC.
- Product Code
- MEA
- PMA / PMN Number
- K022203
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- OTHER
Narratives
THE DEVICE WAS NOT ISOLATED OR IDENTIFIED BY SERIAL NUMBER; THEREFORE, IT WILL NOT BE RETURNED FOR INVESTIGATION.
THE CUSTOMER CONTACT REPORTED AN ADVERSE EVENT WHILE THE PUMP WAS IN USE. ON AN UNSPECIFIED DATE AND TIME, THE PUMP WAS PROGRAMMED TO DELIVER KETAMINE 10MG/DL IN THE CONTINUOUS ONLY MODE AT A RATE OF 19MG/HR, NO DOSE LIMIT WAS SELECTED AND THE DELIVERY WAS STARTED. THE CUSTOMER CONTACT REPORTED THE PATIENT WAS ALSO RECEIVING AN UNSPECIFIED CONCENTRATION OF MORPHINE VIA ANOTHER PCA 3 PUMP. NO SPECIFIC PROGRAMMING PARAMETERS WERE PROVIDED. AFTER APPROXIMATELY 30 MINUTES, THE PATIENT BECAME "UNRESPONSIVE." THE DELIVERY WAS STOPPED. THE PHYSICIAN & THE RAPID RESPONSE TEAM WERE NOTIFIED. THE PATIENT WAS TREATED WITH 100% OXYGEN BY REBREATHER MASK. AFTER AN UNSPECIFIED LENGTH OF TIME, THE PATIENT WAS RESPONSIVE AND FULLY ALERT. THE THERAPIES WERE DISCONTINUED. THE PATIENT WAS TRANSFERRED TO THE INTERMEDIATE CARE UNIT FOR OBSERVATION. THE PUMP WAS REMOVED FROM CLINICAL SERVICE. THERE WERE NO REPORTED ADVERSE PATIENT SEQUELAE. THE CUSTOMER CONTACT REPORTED THAT "THE ACUTE PAIN SERVICE DID NOT THINK THE PUMP WAS AT FAULT. THEY THOUGHT THE INCIDENT WAS DUE TO A CUMULATIVE EFFECT OF THE DRUG AFTER A BOLUS." THOUGH REQUESTED NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | LIFECARE PCA 3 | MEA | HOSPIRA, INC. | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 47 YR | Life Threatening| R | LIFECARE PCA 3 PUMP| KETAMINE MANUFACTURED BY HOSPIRA INC.| MORPHINE |